On March 9, 2024, Dr. Vinod Scaria wrote an article in science page of The Hindu urging for a strong regulatory crackdown to prevent Indian biological samples from being analyzed by foreign commercial entities. However, this article goes over and beyond patient advocacy, and wants a gatekeeping layer to prevent international commercial offerings from accessing any Indian genomics data. Here, …
